10989365 · Active · incorporated 9 years ago · Abingdon
Biotech Biotech & Life Sciences Drug Discovery Series B+
A clinical-stage biotechnology company developing novel antigen modulation technology to guide the immune system for cancer treatment.
https://www.greywolftherapeutics.com/
Grey Wolf Therapeutics Limited is a private limited company registered at Companies House under number 10989365, incorporated on 29 September 2017, with a registered office in Abingdon. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 148 filings for this company, including 8 funding rounds. Its most recent round closed in June 2025, raising £20m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 8 | Jun 2025 | £20m | £4.06 |
| Round 7 | May 2024 | £34.2m | £4.06 |
| Round 6 | Dec 2022 | £29.7m | £4.16 |
| Round 5 | May 2022 | £3.6m | £0.0125 |
| Round 4 | Mar 2021 | £6.6m | £4.16 |
| Round 3 | Jun 2020 | £2.5m | £0.03 |
Showing the 6 most recent of 8 rounds.
Showing the 12 most recent of 148 filings.
See the complete cap table with every shareholder, founder tags, dilution across 47 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.